Barclays PLC
- SEC CIK
- 0000312069
- Latest filing
- Aug 14, 2026
RLMD holding history
Relmada Therapeutics, Inc. in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RLMD overviewAll 13F holders of RLMDFull Q2 2026 holdings
- Shares (Q2 2026)
- 51,234
- Value
- $354.5K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 51,234 | $354.5K | <0.1% | −37,719−42.4% | Reduced | Holders |
| Q1 2026 | 88,953 | $619.1K | <0.1% | +28,953+48.3% | Added | Holders |
| Q4 2025 | 60,000 | $289.8K | <0.1% | +50,000+500.0% | Added | Holders |
| Q3 2025 | 10,000 | $20.1K | <0.1% | +9,999+999,900.0% | Added | Holders |
| Q2 2025 | 1 | $1 | <0.1% | +1 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −145,999−100.0% | Sold out | Holders |
| Q4 2024 | 145,999 | $75.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 145,999 | $473.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 145,999 | $438.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 145,999 | $678.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 145,999 | $604.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 145,999 | $438.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 145,999 | $359.2K | <0.1% | +131,161+884.0% | Added | Holders |
| Q1 2023 | 14,838 | $33.5K | <0.1% | +5,411+57.4% | Added | Holders |
| Q4 2022 | 9,427 | $32.9K | <0.1% | +2,326+32.8% | Added | Holders |
| Q3 2022 | 7,101 | $263.0K | <0.1% | −9,598−57.5% | Reduced | Holders |
| Q2 2022 | 16,699 | $317.0K | <0.1% | +14,999+882.3% | Added | Holders |
| Q1 2022 | 1,700 | $46.0K | <0.1% | +1,700 | New | Holders |